Clinical Trials · NCT06854614
Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- The Cleveland Clinic
- Enrollment
- 150
- Start date
- Mar 2025
- Locations
- 1 site, United States
- Primary endpoint
- Weight change